Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-03-02 @ 6:23 PM
Study NCT ID:
NCT00486460
Status:
UNKNOWN
Last Update Posted:
2007-06-14
First Post:
2007-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-06-13
First Submit QC Date:
None
Study First Post Date:
2007-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-06-13
Last Update Post Date:
2007-06-14
Last Update Post Date Type:
ESTIMATED